Field and laboratory studies of the fate and enantiomeric enrichment of venlafaxine and O-desmethylvenlafaxine under aerobic and anaerobic conditions

Chemosphere

Volumn 88, Issue 1, 2012, Pages 98-105

  Gasser, G ^a,b   Pankratov, I ^b   Elhanany, S ^b   Werner, P ^a,c   Gun, J ^a   Gelman, F ^d   Lev, O ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b Israeli Water Authority   (Israel)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d GEOLOGICAL SURVEY OF ISRAEL   (Israel)

Author keywords

Aerobic; Anaerobic; Micropollutants; Stereoselectivity; Venlafaxine; Wastewater treatment

Indexed keywords

ACTIVATED SLUDGE PROCESS; BIOMOLECULES; LABORATORIES; NATURAL ATTENUATION; RECLAMATION; RIVER POLLUTION; STEREOSELECTIVITY; WASTEWATER TREATMENT;

AEROBIC; AEROBIC AND ANAEROBIC CONDITIONS; ANAEROBIC; CONVENTIONAL ACTIVATED SLUDGES; LABORATORY AND FIELD STUDIES; MICROPOLLUTANTS; VENLAFAXINE; WASTEWATER TREATMENT PLANTS;

METABOLITES;

DESVENLAFAXINE; VENLAFAXINE;

ACTIVATED SLUDGE; ANOXIC CONDITIONS; DOMESTIC WASTE; DRUG; ENVIRONMENTAL FATE; FIELD METHOD; LABORATORY METHOD; METABOLITE; NATURAL ATTENUATION; OXIC CONDITIONS; POLLUTANT SOURCE; RESERVOIR; STREAM; WASTEWATER; WATER TREATMENT;

ACTIVATED SLUDGE; AEROBIC METABOLISM; ANAEROBIC METABOLISM; ARTICLE; DRUG DEGRADATION; ENANTIOMER; ENRICHMENT CULTURE; FIELD STUDY; MICROBIAL ATTENUATION; RESERVOIR; RIVER; STEREOCHEMISTRY; STEREOISOMERISM; WASTE WATER MANAGEMENT;

ISRAEL; JERUSALEM [ISRAEL];

EID: 84859902643     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2012.02.074     Document Type: Article

References (44)

1. Alonso S.G., Catala M., Maroto R.R., Gil J.L.R., de Miguel A.G., Valcarcel Y. Pollution by psychoactive pharmaceuticals in the Rivers of Madrid metropolitan area (Spain). Environ. Int. 2010, 36:195-201.
2. Araujo J.M.M., Rodrigues R.C.R., Eusebio M.F.J., Mota J.P.B. On-line enantiomeric analysis using high-performance liquid chromatography in chiral, separation by simulated moving bed. J. Chromatogr. A 2008, 1189:292-301.
3. Badaloni E., Dacquarica I., Gasparrini F., Lalli S., Misiti D., Pazzucconi F., Sirtori C.R. Enantioselective liquid chromatographic-electrospray mass spectrometric assay of beta-adrenergic blockers: application to a pharmacokinetic study of sotalol in human plasma. J. Chromatogr. B 2003, 796:45-54.
4. Ball S.E., Dennis A., Joann S., Joann K. Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2. Br. J. Clin. Pharmacol. 1997, 43:619-626.
5. Barreiro J.C., Vanzolini K.L., Madureira T.V., Tiritan M.E., Cass Q.B. A column-switching method for quantification of the enantiomers of omeprazole in native matrices of waste and estuarine water samples. Talanta 2010, 82:384-391.
6. Bijlsma L., Sancho J.V., Pitarch E., Ibanez M., Hernandez F. Simultaneous ultra-high-pressure liquid chromatography-tandem mass spectrometry determination of amphetamine and amphetamine-like stimulants, cocaine and its metabolites, and a cannabis metabolite in surface water and urban wastewater. J. Chromatogr. A 2009, 1216:3078-3089.
7. Buser H.R., Poiger T., Muller M.D. Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater. Environ. Sci. Technol. 1999, 33:2529-2535.
8. Calisto V., Esteves V.I. Psychiatric pharmaceuticals in the environment. Chemosphere 2009, 77:1257-1274.
9. Celiz M.D., Tso J., Aga D.S. Pharmaceutical metabolites in the environment: analytical challenges and ecological risks. Environ. Toxicol. Chem. 2009, 28:2473-2484.
10. Cherkaoui S., Rudaz S., Veuthey J.-L. Nonaqueous capillary electrophoresis-mass spectrometry for separation of venlafaxine and its phase I metabolites. Electrophoresis 2001, 22:491-496.
11. Durhan E.J., Lambright C.S., Makynen E.A., Lazorchak J., Hartig P.C., Wilson V.S., Gray L.E., Ankley G.T. Identification of metabolites of trenbolone acetate in androgenic runoff from a beef feedlot. Environ. Health Perspect. 2006, 114:65-68.
12. Elsner M. Stable isotope fractionation to investigate natural transformation mechanisms of organic contaminants: principles, prospects and limitations. J. Environ. Monit. 2010, 12:2005-2031.
13. Feinberg S.S. Correction of venlafaxine- and duloxetine-induced transaminase elevations with desvenlafaxine in a patient with Gilbert's syndrome. CNS Spectr. 2010, 15:53-55.
14. Fono L.J., Sedlak D.L. Use of the chiral pharmaceutical propranolol to identik sewage discharges into surface waters. Environ. Sci. Technol. 2005, 39:9244-9252.
15. Gasser G., Rona M., Voloshenko A., Shelkov R., Tal N., Pankratov I., Elhanany S., Lev O. Quantitative evaluation of tracers for quantification of wastewater contamination of potable water sources. Environ. Sci. Technol. 2010, 44:3919-3925.
16. Gasser G., Rona M., Voloshenko A., Shelkov R., Lev O., Elhanany S., Lange F.T., Scheurer M., Pankratov I. Evaluation of micropollutant tracers. II. Carbamazepine tracer for wastewater contamination from a nearby water recharge system and from non-specific sources. Desalination 2011, 273:398-404.
17. Hijosa V.M., Matamoros V., Martin V.J., Becares E., Bayona J.M. Assessment of full-scale natural systems for the removal of PPCPs from wastewater in small communities. Water Res. 2010, 44:1429-1439.
18. (last visited September 2010). http://drugtopics.modernmedicine.com/top200gen.
19. Kasprzyk-Hordern B. Pharmacologically active compounds in the environment and their chirality. Chem. Soc. Rev. 2010, 39:4466-4503.
20. Kasprzyk-Hordern B., Kondakal V.V.R., Baker D.R. Enantiomeric analysis of drugs of abuse in wastewater by chiral liquid chromatography coupled with tandem mass spectrometry. J. Chromatogr. A 2010, 1217:4575-4586.
21. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman M., Zaugg S.D., Barber L.B., Buxton H.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 2002, 36:1202-1211.
22. Lajeunesse A., Gagnon C., Sauve S. Determination of basic antidepressants and their N-desmethyl metabolites in raw sewage and wastewater using solid-phase extraction and liquid chromatography-tandem mass spectrometry. Anal. Chem. 2008, 80:5325-5333.
23. Lamas J.P., Salgado P.C., Garcia J.C., Llompart M., Cela R., Gomez M. Solid-phase microextraction-gas chromatography-mass spectrometry for the analysis of selective serotonin reuptake inhibitors in environmental water. J. Chromatogr. A 2004, 1046:241-247.
24. Leclercq M., Mathieu O., Gomez E., Casellas C., Fenet H., Buys D.H. Presence and fate of carbamazepine, oxcarbazepine, and seven of their metabolites at wastewater treatment plants. Arch. Environ. Contam. Toxicol. 2009, 56:408-415.
25. Lua A.C., Sutono Y., Chou T.Y. Enantiomeric quantification of (S)-(+)-methamphetamine in urine by an immunoaffinity column and liquid chromatography-electrospray-mass spectrometry. Anal. Chim. Acta 2006, 576:50-54.
26. MacLeod S.L., Wong C.S. Loadings, trends, comparisons, and fate of achiral and chiral pharmaceuticals in wastewaters from urban tertiary and rural aerated lagoon treatments. Water Res. 2010, 44:533-544.
27. MacLeod S.L., Sudhir P., Wong C.S. Stereoisomer analysis of wastewater-derived beta-blockers, selective serotonin re-uptake inhibitors, and salbutamol by high-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2007, 1170:23-33.
28. Matamoros V., Hijosa M., Bayona J.M. Assessment of the pharmaceutical active compounds removal in wastewater treatment systems at enantiomeric level. Ibuprofen and naproxen. Chemosphere 2010, 75:200-205.
29. Metcalfe C.D., Chu S.G., Judt C., Li H., Oakes K.D., Servos M.R., Andrews D.M. Antidepressants and their metabolites in municipal wastewater, and downstream exposure in an urban water shed. Environ. Toxicol. Chem. 2004, 29:79-89.
30. Nikolai L.N., McClure E.L., MacLeod S.L., Wong C.S. Stereoisomer quantification of the beta-blocker drugs atenolol, metoprolol, and propranolol in wastewaters by chiral high-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2006, 1131:103-109.
31. Perez S., Barcelo D. Applications of LC-MS to quantitation and evaluation of the environmental fate of chiral. Trends Anal. Chem. 2008, 27:836-846.
32. Richardson S.D. Environmental mass spectrometry: emerging contaminants and current issues. Anal. Chem. 2010, 82:4742-4774.
33. Schultz M.M., Furlong E.T. Trace analysis of antidepressant pharmaceuticals and their select degradates in aquatic matrixes by LC/ESI/MS/MS. Anal. Chem. 2008, 80:1756-1766.
34. Schultz M., Furlong E.T., Kolpin D.W., Werner S.L., Barber L.B., Blazer V.S., Norris D.O., Vajda A.M. Antidepressant pharmaceuticals in two US effluent-impacted streams: occurrence and fate in water and sediment, and selective uptake in fish neural tissue. Environ. Sci. Technol. 2010, 44:1918-1925.
35. Selke S., Scheurell M., Shah M.R., Hühnerfuss H. Identification and enantioselective gas chromatographic mass-spectrometric separation of O-desmethylnaproxen, the main metabolite of the drug naproxen, as a new environmental contaminant. J. Chromatogr. A 2010, 1217:419-423.
36. Sheldon H., Preskorn M.D., Flockhart D. Guide to psychiatric drug interactions. Primary Psychiatry 2009, 16:45-74.
37. Smith S.W. Chiral toxicology: it's the same thing...only different. Toxicol. Sci. 2009, 110:4-30.
38. Stanley J.K., Ramirez A.J., Mottaleb M., Chambliss C.K., Brooks B.W. Enantiospecific toxicity of the beta-blocker propranolol to Daphnia magna and Pimephales promelas. Environ. Toxicol. Chem. 2006, 25:1780-1786.
39. Stanley J.K., Ramirez A.J., Chambliss C.K., Brooks B.W. Enantiospecific sublethal effects of the antidepressant fluoxetine to a model aquatic vertebrate and invertebrate. Chemosphere 2007, 69:9-16.
40. Tambosi J.L., Yamanaka L.Y., Moreira R.D.P.M., Schroder H.F. Recent research date on the removal of pharmaceuticals from sewage treatment plants (STP). Quim. Nova 2010, 33:411-420.
41. USEPA, 2007. Method 1694, Pharmaceuticals and Personal Care Products in Water, Soil, Sediment, and Biosolids by HPLC/MS/MS: USEPA.
42. Van Breukelen B. Extending the Rayleigh equation to allow competing isotope fractionating pathways to improve quantification of biodegradation. Environ. Sci. Technol. 2007, 41:4004-4010.
43. Wharfe E.S., Winder C.L., Jarvis R.M., Goodacre R. Monitoring the effects of chiral pharmaceuticals on aquatic microorganisms by metabolic fingerprinting. Appl. Environ. Microbiol. 2010, 76:2075-2085.
44. Williams A. Opportunities for chiral agrochemicals. Pestic. Sci. 1996, 46:3-9.